## Abstract ## Purpose To examine the positive reporting bias regarding the link with gadolinium (Gd) exposure and nephrogenic systemic fibrosis (NSF) in patients with renal impairment. This link has impacted strongly the international radiology safety guidelines. We believe that positive reportin
The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance
β Scribed by Anna Lisa Crowley; Han W Kim; Michele Parker; Deneen Spatz; Brenda Hayes; Lubna Bhatti; Christoph J Jensen; Jessica Ngo; John A Papalas; Patrick Pun; John P Middleton; Robert M Judd; Raymond J Kim
- Publisher
- BioMed Central
- Year
- 2012
- Tongue
- English
- Weight
- 132 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1097-6647
No coin nor oath required. For personal study only.
β¦ Synopsis
The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance is low (0.026% overall and 1.274% in those subjects with CKD Stage 5 on hemodialysis).
π SIMILAR VOLUMES
## Abstract From May 2007 to January 2008, patients with Stage 3β5 chronic kidney disease (CKD) undergoing gadobenate dimeglumine (GBD)βenhanced magnetic resonance (MR) examinations were included in the retrospective investigation. The electronic medical records were reviewed to assess the prevalen
In this study, we have used equilibium contrast CMR (EQ-CMR) to assess the interstium volume of patients after atrial redirection surgery, finding higher amounts than in healthy volunteers and correlations with known clinical markers of disease.
## Purpose: To develop a safe functional magnetic resonance imaging (fmri) procedure for auditory assessment of deaf subjects. ## Materials and methods: A gold-plated tungsten electrode has been developed which has zero magnetic susceptibility. used with carbon leads and a carbon reference pad, i